SCHEMBL22764962

SCHEMBL22764962

CS(=O)(=O)Nc1cccc2ccc(-c3ccc(S(=O)(=O)Nc4cccc5cccnc45)cc3)nc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 10/20 0.66
HTT P42858 3/20 0.66
ALOX15 P16050 2/20 0.66
SLC40A1 Q9NP59 9/20 0.65
TDP1 Q9NUW8 7/20 0.65
KMT2A Q03164 4/20 0.65
AGTR1 P30556 2/20 0.65
ALDH1A1 P00352 2/20 0.65
OPRK1 P41145 2/20 0.65
NPSR1 Q6W5P4 2/20 0.65
MITF O75030 1/20 0.65
S1PR4 O95977 1/20 0.65
LMNA P02545 1/20 0.65
MAPT P10636 1/20 0.65
S1PR1 P21453 1/20 0.65
CKS1B P61024 1/20 0.65
SKP2 Q13309 1/20 0.65
NFKBIA P25963 2/20 0.62
G6PD P11413 1/20 0.62
METAP2 P50579 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13485950 0.81 SLC40A1 (0.80) GLO1HTTALOX15SLC40A1TDP1
SCHEMBL6862410 0.81 GLO1 (1.00) GLO1HTTALOX15SLC40A1TDP1
SCHEMBL29941063 0.81 GLO1 (1.00) GLO1HTTALOX15SLC40A1TDP1
SCHEMBL13485924 0.80 GLO1 (0.84) GLO1HTTALOX15SLC40A1TDP1
SCHEMBL4471796 0.79 TDP1 (1.00) GLO1HTTSLC40A1TDP1KMT2A
SCHEMBL13485929 0.78 SLC40A1 (0.92) GLO1HTTALOX15SLC40A1TDP1
SCHEMBL15299831 0.78 TDP1 (0.97) GLO1HTTSLC40A1TDP1KMT2A
SCHEMBL2337402 0.78 TDP1 (0.97) GLO1HTTSLC40A1TDP1KMT2A
SCHEMBL5572103 0.78 TDP1 (0.97) GLO1HTTSLC40A1TDP1KMT2A
SCHEMBL30925450 0.78 SLC40A1 (0.70) GLO1HTTSLC40A1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691949-B2 Quinoline sulfonamide compounds and their use as antibacterial agents OTAGO INNOVATION LIMITED (NZ) 2023-07-04 US disclosed
US-20200385354-A1 Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents OTAGO INNOVATION LIMITED (NZ) 2020-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691949-B2 Quinoline sulfonamide compounds and their use as antibacterial agents NQO2, SDHA, SIRT5 GLO1 369/4885HTT 3885/4885ALOX15 4586/4885
US-20200385354-A1 Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents NQO2, SDHA, SIRT5 GLO1 369/4885HTT 3885/4885ALOX15 4586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.